We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Danaher Acquires Integrated DNA Technologies

Danaher Corporation has entered into a definitive agreement to acquire Integrated DNA Technologies (IDT), a privately held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. More...
13 Mar 2018
Image: The Vivalytic all-in-one fully automated solution for molecular diagnostics (Photo courtesy of Randox Laboratories and Bosch Healthcare Solutions).

Randox and Bosch Partner to Launch Molecular Diagnostics Platform

Global healthcare diagnostics manufacturer Randox Laboratories has partnered with Bosch Healthcare Solutions GmbH to launch Vivalytic, an all-in-one fully automated solution for molecular diagnostics. More...
01 Mar 2018

Immunofluorescence Assay Market Worth USD 2 Billion by 2023

The global immunofluorescence assay market estimated to be worth USD 1.51 billion in 2018 and is projected to grow at a CAGR of 5.8% to reach USD 2.01 billion by 2023, driven by the growing prevalence of chronic diseases, increasing R&D spending, and rise in healthcare spending. More...
01 Mar 2018
Image: Siemens Healthineers announced that completion of the planned IPO of Siemens Healthineers AG is expected in the first half of calendar year 2018 (Photo courtesy of Siemens Healthineers).

Siemens Healthineers AG IPO Planned for First Half of 2018

Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions. More...
27 Feb 2018

Molecular POC Market to Reach USD 510 Million by 2023

The molecular point-of-care market (POC), consisting of systems with molecular capability used in decentralized test environments, was worth an estimated USD 165 million in 2017 and is expected to continue growing in the double-digits to reach USD 510 million in 2023. More...
27 Feb 2018
Image: The global market for POC blood glucose monitoring devices is expected to be driven mainly by public and private initiatives to reduce diabetic cases (Photo courtesy of Roche).

Top Factors Driving Global POC Glucose Monitoring Devices Market

The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. These are the latest findings of Technavio Research, a global technology research and advisory company. More...
23 Feb 2018
Image: Qiagen plans to acquire diagnostics developer STAT-Dx for up to $191 million, in a deal designed to facilitate the buyer\'s planned launch later this year of the QIAstat-Dx platform, based on STAT-Dx’s proprietary DiagCORE technology (Photo courtesy of STAT-Dx).

QIAGEN Enters into Agreement to Acquire STAT-Dx

QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries. More...
13 Feb 2018
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Manual Pipetting Aid
Pipette Controllers macro
New
Steam Sterilizer
Hi Vac II Line


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
INTEGRA BIOSCIENCES AG